Dlk Investment Management, LLC Passage Bio, Inc. Put Options Transaction History
Dlk Investment Management, LLC
- $239 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding PASG
# of Institutions
45Shares Held
36.4MCall Options Held
50.3KPut Options Held
0-
Lynx1 Capital Management LP San Juan, PR9.26MShares$2.78 Million1.2% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.03MShares$2.11 Million0.08% of portfolio
-
Vestal Point Capital, LP New York, NY6.1MShares$1.83 Million0.15% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$749,3761.97% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$736,7400.01% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $16.3M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...